Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07793435 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase 1/2 Trial of ADI-212 in mCRPC

Name: A Phase 1/2 Trial of ADI-212 in mCRPC — clinical trial record (NCT07793435)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1/2

SponsorAdicet Therapeutics

Started2026-09

View on ClinicalTrials.gov ↗

This is a Phase 1/2 multicenter, open-label, dose finding and dose expansion study of ADI-212 in participants with metastatic castration-resistant prostate cancer (mCRPC)

Trial Details

NCT Number	NCT07793435
Lead Sponsor	Adicet Therapeutics
Conditions	Prostate Cancer Metastatic
Enrollment	12 participants
Start Date	2026-09
Primary Completion	2028-10 (estimated)
Study Completion	2029-10 (estimated)
Updated on ClinicalTrials.gov	2026-08-31